1. |
Mottillo S, Filion KB, Genest J , et al. The metabolic syndrome and cardiovascular risk. A systematic review and meta-analysis. J Am Coll Cardiol 2010; 56(14):1113-32. doi: 10.1016/j.jacc.2010.05.034.
|
2. |
Fox CS, Coady S, Sorlie PD , et al. Trends in cardiovascular complications of diabetes. JAMA 2004; 292(20):2495-9. doi: 10.1001/jama.292.20.2495.
|
3. |
Outinen PA, Sood SK, Liaw PC , et al. Characterization of the stress-inducing effects of homocysteine. Biochem J 1998; 332(1):213-21.
|
4. |
Pollex RL, Mamakeesick M, Zinman B , et al. Methylenetetrahydrofolate reductase polymorphism 677C>T is associated with peripheral arterial disease in type 2 diabetes. Cardiovasc Diabetol 2005; 4(1):17. doi: 10.1186/1475-2840-4-17.
|
5. |
Hoogeveen EK, Kostense PJ, Beks PJ , et al. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. Arterioscler Thromb Vasc Biol 1998; 18(1):133-8. doi: 10.1161/01.ATV.18.1.133.
|
6. |
Hackam DG . Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA 2003; 290(7):932-40. doi: 10.1001/jama.290.7.932.
|
7. |
Klerk M, Verhoef P, Clarke R , et al. MTHFR 677C T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 2002; 288(16):2023-31. doi: 10.1001/jama.288.16.2023.
|
8. |
Audelin MC, Genest J . Homocysteine and cardiovascular disease in diabetes mellitus. Atherosclerosis 2001; 159:497-511. doi: 10.1016/s0021-9150(01)00531-7.
|
9. |
Harmon DL, Woodside JV, Yarnell JW , et al. The common ‘thermolabile’ variant of methylenetetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. QJM 1996; 89(8):571-7. doi: 10.1093/qjmed/89.8.571.
|
10. |
van der Put NM, Gabreëls F, Stevens EM , et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998; 62(5):1044-51. doi: 10.1086/301825.
|
11. |
Frosst P, Blom HJ, Milos R , et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10(1):111-3. doi: 10.1038/ng0595-111.
|
12. |
Arnadottir M, Hultberg B, Nilsson-Ehle P , et al. The effect of reduced glomerular filtration rate on plasma total homocysteine concentration. Scand J Clin Lab Invest 1996; 56(1):41-6. doi: 10.3109/00365519609088586.
|
13. |
Rozycka A, Jagodzinski PP, Kozubski W , et al. Homocycsteine level and mechanisms of injury in Parkinson’s disease as related to MTHFR, MTR, THFD1 genes polymorphisms and L-Dopa treatment. Curr Genomics 2013; 14(8):534-42. doi: 10.2174/1389202914666131210210559.
|
14. |
Krumdieck CL, Prince CW . Mechanisms of homocysteine toxicityon connective tissues: implications for the morbidity of aging. J Nutr 2000; 130(2S Suppl):365S-8S. doi: 10.1093/jn/130.2.365S.
|
15. |
Haynes WG . Hyperhomocysteinaemia, vascular function and athersclerosis: effects of vitamins. Cadiovasc Drugs Ther 2002; 16(5):391-9.
|
16. |
Glueck CJ, Shaw P, Lang JE , et al. Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients. Am J Cardiol 1995; 75(2):132-6. doi: 10.1016/s0002-9149(00)80061-2.
|
17. |
Goyette P, Sumner JS, Milos R , et al. Human methylenetetrahydrofolate reductase: isolation of cDNA mapping and mutation identification. Nat Genet 1994; 7(4):551.
|
18. |
Doshi SN, Goodfellow J, Lewis MJ , et al. Homocysteine and endothelial function. Cardiovasc Res 1999; 42(3):578-82. doi: 10.1016/s0008-6363(99)00029-2.
|
19. |
Hanson NQ, Aras O, Yang F . C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. Clin Chem 2001; 47(4):661-6.
|
20. |
Spiridonova MG, Stepanov VA, Pyzyrev VP . Relationship between polymorphism C677T of the methylenetetrahydrofolate reductase gene with clinical symptoms of coronary atherosclerosis. Genetika 2000; 36(9):1269-73.
|
21. |
Liang R, Zhou Y, Xie J , et al. Association of C677T gene polymorphisms of methylenetetrahydrofolate reductase and plasma homocysteine level with hyperlipidemia. Nan Fang Yi Ke Da Xue Xue Bao 2014; 34(8):1195-8. doi: 10.3969/j.issn.1673-4254.2014.08.25.
|
22. |
Mao Y, Fan YH, Bai J , et al. Polymorphism of methylenetetrahydrofolate reductase and association with diseases. Int J Genetics 1998; 15(5):38-40.
|
23. |
Cortese C . MTHFR gene polymorphism, homocysteine and cardiovascular disease. Public Health Nutr 2001; 4(2b):493-7. doi: 10.1079/PHN2001159.
|
24. |
Errera FI, Silva ME, Yeh E , et al. Effect of polymorphisms of the MTHFR and APOE genes on susceptibility to diabetes and severity of diabetic retinopathy in Brazilian patients. Braz J Med Biol Res 2006; 39(7):883-8. doi: 10.1590/S0100-879X2006000700005.
|
25. |
Benrahma H, Abidi O, Melouk L , et al. Association of the C677T polymorphism in the human methylenetetrahydrofolate reductase (MTHFR) gene with the genetic predisposition for type 2 diabetes mellitus in a Moroccan population. Genet Test Mol Biomarkers 2012; 16(5):383-7. doi: 10.1089/gtmb.2011.0179.
|
26. |
Sun J, Xu Y, Zhu Y . Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients. Diabetes Res Clin Pract 2004; 64(3):185-90. doi: 10.1016/j.diabres.2003.10.022.
|
27. |
Doupis J, Eleftheriadou I, Kokkinos A , et al. Acute hyperhomocysteinemia impairs endothelium function in subjects with type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2010; 118(7):453-8. doi: 10.1055/s-0030-1248290.
|
28. |
Aso Y, Yoshida N, Okumura K , et al. Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia. Clin Chim Acta 2004; 348(1-2):139-45. doi: 10.1016/j.cccn.2004.05.006.
|
29. |
Araki A, Sako Y, Ito H . Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatment. Atherosclerosis 1993; 103(2):149-57. doi: 10.1016/0021-9150(93)90258-v.
|
30. |
Fekih-Mrissa N, Mrad M, Ibrahim H , et al. Methylenetetrahydrofolate reductase (MTHFR) (C677T and A1298C) polymorphisms and vascular complications in patients with type 2 diabetes. Can J Diabetes 2017; 41(4):366-71. doi: 10.1016/j.jcjd.2016.11.007.
|
31. |
Sun JZ, Xu Y, Lu H . Polymorphism of the methylenetetrahydrofolate reductase gene association with homocysteine and ischemic stroke in type 2 diabetes. Neurol India 2009; 57(5):589-93. doi: 10.4103/0028-3886.57808.
|